About SimBioSys
SimBioSys is a private company based in Chicago, Illinois. It has reported $6,146,777 raised in two offerings on Form D since November 2018. Its chief executive is Stacey Stevens.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 20, 2024 | Jan 6, 2025 | $5,246,777of $8.0M target | 13 | $403K | Equity, OptionsRule 506(b) | Form D ↗ |
| Nov 1, 2018 | Nov 20, 2018 | $900,000of $1.3M target | 3 | $300K | DebtRule 506(b) | Form D ↗ |
| Total, two offerings | $6,146,777 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on SimBioSys's Form D filed Jan 6, 2025.
VC
Vikram Chaudhery
Director
RA
Ronnie Andrews
Director
WH
William Hyun
Director
JP
Joseph Peterson
Executive officer and director
SS
Stacey Stevens
Chief Executive Officer and director
Earlier filings also listed John Cole (executive officer, last listed Nov 2018).